1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue
1.4 Market Analysis by Type
1.4.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Barium-based Contrast Media
1.4.3 Iodinated Contrast Media
1.4.4 Gadolinium-based Contrast Media
1.4.5 Microbubble Contrast Media
1.5 Market by Application
1.5.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Application: 2021-2026
1.5.2 Radiology
1.5.3 Interventional Radiology
1.5.4 Interventional Cardiology
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market
1.8.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Contrast Agents for Magnetic Resonance Imaging (MRI) Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Market Share by Region (2015-2020)
3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Revenue Market Share by Region (2015-2020)
3.3 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume
3.3.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2015-2020)
3.3.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume
3.4.1 East Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume (2015-2020)
3.5.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume (2015-2020)
3.6.1 South Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume (2015-2020)
3.7.1 Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume (2015-2020)
3.8.1 Middle East Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume (2015-2020)
3.9.1 Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume (2015-2020)
3.10.1 Oceania Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume (2015-2020)
3.11.1 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2015-2020)
3.11.2 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume (2015-2020)
3.12.1 Rest of the World Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Market Share by Type (2015-2020)
14.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Revenue Market Share by Type (2015-2020)
14.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Volume by Application (2015-2020)
15.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Contrast Agents for Magnetic Resonance Imaging (MRI) Business
16.1 GE Healthcare (US)
16.1.1 GE Healthcare (US) Company Profile
16.1.2 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.1.3 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 J.B. Chemicals and Pharmaceuticals (India)
16.2.1 J.B. Chemicals and Pharmaceuticals (India) Company Profile
16.2.2 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.2.3 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Guerbet (France)
16.3.1 Guerbet (France) Company Profile
16.3.2 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.3.3 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Bracco Imaging (Italy)
16.4.1 Bracco Imaging (Italy) Company Profile
16.4.2 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.4.3 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Unijules Life Sciences (India)
16.5.1 Unijules Life Sciences (India) Company Profile
16.5.2 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.5.3 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Bayer HealthCare (Germany)
16.6.1 Bayer HealthCare (Germany) Company Profile
16.6.2 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.6.3 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Taejoon Pharm (South Korea)
16.7.1 Taejoon Pharm (South Korea) Company Profile
16.7.2 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.7.3 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Daiichi Sankyo (Japan)
16.8.1 Daiichi Sankyo (Japan) Company Profile
16.8.2 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.8.3 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Lantheus (US)
16.9.1 Lantheus (US) Company Profile
16.9.2 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.9.3 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Spago Nanomedicine (Sweden)
16.10.1 Spago Nanomedicine (Sweden) Company Profile
16.10.2 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.10.3 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Jodas (India)
16.11.1 Jodas (India) Company Profile
16.11.2 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.11.3 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Magnus Health (India)
16.12.1 Magnus Health (India) Company Profile
16.12.2 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.12.3 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturing Cost Analysis
17.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Contrast Agents for Magnetic Resonance Imaging (MRI)
17.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors List
18.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Contrast Agents for Magnetic Resonance Imaging (MRI) (2021-2026)
20.2 Global Forecasted Revenue of Contrast Agents for Magnetic Resonance Imaging (MRI) (2021-2026)
20.3 Global Forecasted Price of Contrast Agents for Magnetic Resonance Imaging (MRI) (2015-2026)
20.4 Global Forecasted Production of Contrast Agents for Magnetic Resonance Imaging (MRI) by Region (2021-2026)
20.4.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2021-2026)
20.4.3 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2021-2026)
20.4.7 Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2021-2026)
20.4.9 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
21.2 East Asia Market Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
21.3 Europe Market Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Countriy
21.4 South Asia Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
21.5 Southeast Asia Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
21.6 Middle East Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
21.7 Africa Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
21.8 Oceania Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
21.9 South America Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
21.10 Rest of the world Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer